Axsome Therapeutics SG&A Expense (Quarterly) Insights

Axsome Therapeutics Inc (AXSM)

73.47 -0.74 (-1.00%) USD | NASDAQ | May 31, 16:00

73.39 -0.08 (-0.11%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	98.97M
December 31, 2023	86.81M
September 30, 2023	83.19M
June 30, 2023	78.94M
March 31, 2023	74.19M
December 31, 2022	61.50M
September 30, 2022	40.89M
June 30, 2022	31.16M
March 31, 2022	25.70M
December 31, 2021	18.83M
September 30, 2021	20.23M
June 30, 2021	16.34M
March 31, 2021	11.25M
December 31, 2020	10.36M
September 30, 2020	6.331M
June 30, 2020	7.236M
March 31, 2020	4.970M
December 31, 2019	5.223M
September 30, 2019	3.112M
June 30, 2019	2.445M

Date	Value
March 31, 2019	2.818M
December 31, 2018	2.299M
September 30, 2018	2.203M
June 30, 2018	2.439M
March 31, 2018	2.411M
December 31, 2017	1.950M
September 30, 2017	1.826M
June 30, 2017	1.743M
March 31, 2017	1.687M
December 31, 2016	1.819M
September 30, 2016	1.639M
June 30, 2016	1.529M
March 31, 2016	1.357M
December 31, 2015	0.9466M
September 30, 2015	0.4994M
June 30, 2015	0.4564M
March 31, 2015	0.5168M
December 31, 2014	0.6008M
September 30, 2014	0.3952M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.445M

Minimum

Jun 2019

98.97M

Maximum

Mar 2024

34.38M

Average

19.53M

Median

SG&A Expense (Quarterly) Benchmarks